The English Institute of Sport (EIS) has partnered with Mint Diagnostics to develop a new at-home test for female athletes which will provide information on hormone levels, which the pair say could provide opportunities to progress female health, performance and wellbeing.
The pair say the technology, called Hormonix, will provide ‘clear, rapid and accurate’ information on hormone levels through a saliva sample.
“The EIS Performance Innovation Team aims to fast-track new ideas from industries outside of sport that have the potential to positively impact British athletes’ health and performance,” said Dr Matt Parker, Director, EIS Performance Innovation.
“By working in partnership with Mint Diagnostics, we are redefining the role hormone data can have in these areas.
“The Hormonix technology allows us to continue supporting athlete health and performance remotely, away from centralised locations and in the athlete’s own environment – responding to the way technology and healthcare is heading.”
Stefano Borini, Co-Founder and CEO, Mint Diagnostics, added: “We’ve been collaborating with the EIS on this technology for the past three years, and we’re truly excited about its potential.
“Hormonix is a major development in female health, enabling us to monitor and apply hormone data in ways we’ve never been able to do before. Whilst the development of Hormonix technology is being focused on elite athletes, the technology has the potential to cross over to enhancing female health in society.”
The technology is currently in the final stages of development, but the EIS and Mint Diagnostics say the technology is expected to be available to athletes in October.